fluorodeoxyglucose f18 has been researched along with Fatigue Syndrome, Chronic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barberon, B; Coulange, M; Guedj, E; Laine, N; Mairal, E | 1 |
| Abrivard, M; Aoun-Sebati, M; Authier, FJ; Blanc-Durand, P; Emsen, B; Hodel, J; Itti, E; Kauv, P; Luciani, A; Sahbai, S | 1 |
| Bartenstein, P; Egle, UT; Hardt, J; Nix, WA; Schreckenberger, M; Siessmeier, T | 1 |
| Andersen, AB; Gerstoft, J; Højgaard, L; Høyer-Hansen, G; Kjaer, A; Law, I; Lebech, AM; Ostrowski, SR; Ullum, H | 1 |
| Berns, GS; Capuron, L; Demetrashvili, MF; Fornwalt, FB; Lawson, DH; Miller, AH; Nemeroff, CB; Pagnoni, G; Woolwine, B | 1 |
| Bianchin, G; Chierichetti, F; Ferlin, G; Simonelli, C; Tavio, M; Tirelli, U; Zanco, P | 1 |
| Abdel-Dayem, HM; Abu-Judeh, HH; el-Zeftawy, H; Kumar, M; Levine, S; Lou, JQ; Naddaf, S | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
Topics: Adult; Basal Ganglia; Behavioral Symptoms; Brain Mapping; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
6 other study(ies) available for fluorodeoxyglucose f18 and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Reversible widespread brain
Topics: Brain; Fatigue Syndrome, Chronic; Fluorodeoxyglucose F18; Humans; Hyperbaric Oxygenation; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI.
Topics: Blood Circulation; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Young Adult | 2019 |
Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome.
Topics: Adult; Brain; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Self-reported fatigue common among optimally treated HIV patients: no correlation with cerebral FDG-PET scanning abnormalities.
Topics: Adult; Aged; AIDS Dementia Complex; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cerebral Cortex; Cohort Studies; Comorbidity; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Glucose; HIV Infections; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Positron-Emission Tomography; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2006 |
Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.
Topics: Adult; Brain; Case-Control Studies; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Comparison of SPET brain perfusion and 18F-FDG brain metabolism in patients with chronic fatigue syndrome.
Topics: Brain; Fatigue Syndrome, Chronic; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1998 |